Skip to content

Clinical trials

Completed Phase 4 Hematologic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 4 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20081
20122
20131
20141
20181
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Amsterdam UMC, location VUmc1
Centre Hospitalier Régional d'Orléans1
Eli Lilly and Company1
H. Lee Moffitt Cancer Center and Research Institute1
Jens Rikardt Andersen1
Johns Hopkins University1
Mansoura University1
Universitaire Ziekenhuizen KU Leuven1
Zhejiang University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms11
Neoplasms2
Neoplasms, Plasma Cell2
Acquired Immunodeficiency Syndrome1
Diabetes Mellitus, Type 21
Febrile Neutropenia1
Fever1
Hypergammaglobulinemia1
Infections1
Invasive Fungal Infections1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.